Announcements Trials
Browse Landscape

Status

Completed 11Terminated 3Recruiting 3Unknown 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Plasma cell 1Gastrointestinal 1Dermatologic 1

Conditions

Uveal Melanoma 1Melanoma 1Liver Neoplasms 1

Interventions

regorafenib 3zanidatamab 1peginterferon alfa-2a 1pegilodecakin 1onvansertib 1omburtamab I-131 1guselkumab 1derazantinib 1avapritinib 1Tenofovir 1Melphalan 1Imatinib Mesylate 1IMM-101 1IFL protocol 1HMPL-013 1Everolimus 1Brachytherapy 1Bevacizumab 1AM0010 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Melphalan × Gastrointestinal × Clear all
NCT01728051 2013-10-23

Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

Delcath Systems Inc.

No longer available
DermatologicGastrointestinal

Uveal Melanoma, Liver Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡